-
1Academic Journal
المؤلفون: Pulini, S, Rupoli, S, Goteri, G, Alterini, R, Fabbri, A, Quaglino, P, Pimpinelli, N., CANTONETTI, MARIA
المساهمون: Pulini, S, Rupoli, S, Goteri, G, Alterini, R, Cantonetti, M, Fabbri, A, Quaglino, P, Pimpinelli, N
مصطلحات موضوعية: EMTREE drug terms: bexarotene, doxorubicin, gemcitabine EMTREE medical terms: cancer staging, cancer survival, conference paper, cutaneous T cell lymphoma, drug dose escalation, drug efficacy, drug safety, drug tolerability, human, low drug dose, monotherapy, prognosi, treatment response, Settore MED/15 - MALATTIE DEL SANGUE, Settore MED/06 - ONCOLOGIA MEDICA
Relation: volume:3; issue:1; firstpage:94; lastpage:95; journal:HEMATOLOGY MEETING REPORTS; http://hdl.handle.net/2108/69174
الاتاحة: http://hdl.handle.net/2108/69174
-
2
المؤلفون: Pulini, S., Rupoli, S., Goteri, G., Alterini, R., Maria CANTONETTI, Fabbri, A., Quaglino, P., Pimpinelli, N.
المصدر: Scopus-Elsevier
مصطلحات موضوعية: drug safety, Settore MED/06 - Oncologia Medica, treatment response, gemcitabine EMTREE medical terms: cancer staging, cutaneous T cell lymphoma, doxorubicin, drug efficacy, low drug dose, EMTREE drug terms: bexarotene, monotherapy, human, prognosis, cancer survival, conference paper, drug dose escalation, drug tolerability, Settore MED/15 - Malattie del Sangue